Cancidas and acute myeloid leukaemia Patient Reports February 10, 2012

Cancidas Side Effects Report #5019083-3
Cancidas side effect was reported by a Physician from MALAYSIA on May 24, 2006. Female patient, 47 years of age, was diagnosed with systemic mycosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia. Cancidas dosage: unknown. During the same period patient was treated with VORICONAZOLE, AMPHOTERICIN B. Patient died on 05/24/2006.

Cancidas Side Effects Report #5315215-8
Cancidas side effect was reported by a Physician from UNITED STATES on Apr 23, 2007. Female patient, 21 years of age, was diagnosed with lung neoplasm and was treated with Cancidas. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, infection . Cancidas dosage: unknown. During the same period patient was treated with CHOLESTEROL AND AMPHOTERICIN B AND DISTEAROYLPHOSPHATIDYLGLYCEROL AND. Patient died.

Cancidas Side Effects Report #5334088-0
Cancidas side effect was reported by a Physician from UNITED STATES on May 18, 2007. Female patient, 21 years of age, was diagnosed with lung neoplasm and was treated with Cancidas. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, infection . Cancidas dosage: unknown. During the same period patient was treated with AMPHOTERICIN B AND CHOLESTEROL AND DISTEAROYLPHOSPHATIDYLGLYCEROL AND. Patient died.

Cancidas Side Effects Report #5053924-9
Cancidas side effect was reported by a Physician from MALAYSIA on May 24, 2006. Male patient, 15 years of age, weighting 110.2 lb, was diagnosed with fungal infection  and was treated with Cancidas. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, condition aggravated, prescribed overdose, sepsis . Cancidas dosage: unknown. Patient died on 05/23/2006.


Cancidas Side Effects Report #5564220-5
Cancidas side effect was reported by a Physician from BELGIUM on Dec 11, 2007. Male patient, 65 years of age, weighting 172.0 lb, was diagnosed with febrile neutropenia, cough and was treated with Cancidas. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia. Cancidas dosage: unknown. During the same period patient was treated with MEROPENEM. Patient died on 11/11/2007.

Cancidas Side Effects Report #5332741-6
Cancidas side effect was reported by a Physician from ITALY on May 15, 2007. Female patient, child 7 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: acute graft versus host disease, acute myeloid leukaemia, bronchopulmonary aspergillosis, chronic graft versus host disease, hyperglycaemia, metabolic encephalopathy. Cancidas dosage: unknown. During the same period patient was treated with AMPHOTERICIN B, FLUDARABINE PHOSPHATE, ETOPOSIDE, MELPHALAN, ANTILYMPHOCYTE IMMUNOGLOBULIN, METHOTREXATE, CYCLOSPORINE. Patient died.

Cancidas Side Effects Report #5337586-9
Cancidas side effect was reported by a Physician from ITALY on May 15, 2007. Female patient, child 7 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: acute graft versus host disease, acute myeloid leukaemia, bronchopulmonary aspergillosis, chronic graft versus host disease, hyperglycaemia, metabolic encephalopathy. Cancidas dosage: unknown. During the same period patient was treated with AMPHOTERICIN B, FLUDARABINE PHOSPHATE, ETOPOSIDE, MELPHALAN, ANTILYMPHOCYTE IMMUNOGLOBULIN, METHOTREXATE, CYCLOSPORINE. Patient died.

Cancidas Side Effects Report #5412948-X
Cancidas side effect was reported by a Physician from ITALY on Aug 03, 2007. Female patient, child 7 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: acute graft versus host disease, acute myeloid leukaemia, bronchopulmonary aspergillosis, chronic graft versus host disease, hyperglycaemia, metabolic encephalopathy. Cancidas dosage: unknown. During the same period patient was treated with AMPHOTERICIN B. Patient died.

Cancidas Side Effects Report #5444930-0
Cancidas side effect was reported by a Consumer or non-health professional from KOREA, REPUBLIC OF on Aug 22, 2007. Male patient, 60 years of age, was diagnosed with aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, acute respiratory distress syndrome, condition aggravated, pneumonia fungal, pulmonary haemorrhage, septic shock. Cancidas dosage: 70 MG DAILY IV, 50 MG DAILY IV. During the same period patient was treated with AMIKACIN SULPHATE, CEFTAZIDIME, CLINDAMYCIN PHOSPHATE, IMIPENEM, ITRACONAZOLE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, TEICOPLANIN. Patient was hospitalized and became disabled. Patient died.


Cancidas Side Effects Report #5450964-2
Cancidas side effect was reported by a Consumer or non-health professional from KOREA, REPUBLIC OF on Sept 06, 2007. Male patient, 60 years of age, was diagnosed with aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, acute respiratory distress syndrome, condition aggravated, pneumonia fungal, pulmonary haemorrhage, septic shock. Cancidas dosage: 70 MG/DAILY IV; 50 MG/DAILY IV. During the same period patient was treated with AMIKACIN SULPHATE, CEFTAZIDIME, CLINDAMYCIN PHOSPHATE, IMIPENEM, ITRACONAZOLE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, TEICOPLANIN. Patient was hospitalized and became disabled. Patient died.

Cancidas Side Effects Report #4791767-1
Cancidas side effect was reported by a Consumer or non-health professional from BELGIUM on Sept 23, 2005. Male patient, 58 years of age, was diagnosed with aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, condition aggravated, pneumonia aspergillus. Cancidas dosage: 50 MG, IV. During the same period patient was treated with VIREAD, ANTIMICROBIAL. Patient was hospitalized. Patient died.

Cancidas Side Effects Report #4844716-1
Cancidas side effect was reported by a Consumer or non-health professional from BELGIUM on Nov 10, 2005. Male patient, 58 years of age, was diagnosed with aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, condition aggravated, pneumonia aspergillus. Cancidas dosage: 50 MG IV. During the same period patient was treated with VIREAD. Patient was hospitalized. Patient died.

Cancidas Side Effects Report #5158795-8
Cancidas side effect was reported by a Consumer or non-health professional from GERMANY on Nov 03, 2006. Male patient, 76 years of age, was treated with Cancidas. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia. Cancidas dosage: 50 MG/DAILY IV. During the same period patient was treated with CODEINE PHOSPHATE, PANTOPRAZOLE, RAMIPRIL, TORSEMIDE. Patient recovered.